* Received unconditional FDA approval for marketing in the
US for its prescription drug Ameluz in combination the PDT-lamp
BF-RhodoLED for lesion-directed and field-directed treatment of
mild to…
The post BRIEF-Biofrontera: FDA grants approval for Ameluz in the USA appeared first on NASDAQ.